Investigator
Richard E Pratley
ADVENTHEALTH ORLANDO · funded by NIDDK
- Companies
- 3
- Grants
- 3
- Non-dilutive funding
- $3.5M
- First award
- Sep 25, 2022
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Sep 11, 2025.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- ADVENTHEALTH ORLANDOMomentum in another area
Rare diseasePhase I
- ADVENTHEALTH ORLANDOMomentum in another area
NeuroGrant-only
- ADVENTHEALTH ORLANDOMomentum in another area
NeuroGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- U01
Ketone Monitoring Approaches for DKA Risk Mitigation in People with T1D on Adjunctive SGLT2 Inhibitors (KARMA)
$2.5MSep 11, 2025NIDDKADVENTHEALTH ORLANDONIH RePORTER · 11127155 (opens the source filing in a new tab)
- U01
Advanced Insulin Delivery to Reduce Impaired Awareness of Hypoglycemia in a T1D Cohort (AIDRIAHT1C)
$328kSep 25, 2022NIDDKADVENTHEALTH ORLANDONIH RePORTER · 11076628 (opens the source filing in a new tab)
- U01
Advanced Insulin Delivery to Reduce Impaired Awareness of Hypoglycemia in a T1D Cohort (AIDRIAHT1C)
$741kSep 25, 2022NIDDKADVENTHEALTH ORLANDONIH RePORTER · 11319846 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources